About 1 500 reports

The global biopharmaceutical excipients market is expected to grow at a CAGR of 7.56% during 2022-2027. Excipients are fundamental components of any biopharmaceutical drug product, which act as active ingredients, stability enhancers, emulsifying and suspending agents, binders, preservatives, antioxidants, and lubricants. These differ...

  • Biopharmaceutical Excipient
  • World
  • Cancer Incidence
  • Mortality Rate

Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) pipeline Target constitutes close to 8 molecules. Out...

  • Biopharmaceutical
  • Lung Cancer
  • Heart Attack
  • World
  • Cause-Specific Mortality Rate
  • Energy Supply

The biopharmaceutical tubing market is expected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million in 2021; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The factors increasing elderly population in world, and rising demand for minimally invasive procedures are contributing to the market growth. However,...

  • Biopharmaceutical
  • World
  • APAC
  • Europe
  • Chronic Disease Prevalence
  • Health Expenditure

Toll Like Receptor 8 (CD288 or TLR8) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Toll Like Receptor 8 - Drugs In Development, 2022’; Toll Like Receptor 8 (CD288 or TLR8) pipeline...

  • Cancer
  • Pharmaceutical
  • Therapy
  • Biopharmaceutical
  • Drug Development
  • World
  • Prescription Drug Sales

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021 Summary According to the recently published report ’Alpha 2C Adrenergic Receptor – Drugs In Development, 2021’; Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic...

  • Pharmaceutical
  • Biopharmaceutical
  • World
  • Pharmaceutical Registrations
  • Health Provider Density

Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Janus kinase 2 is a non-receptor tyrosine...

  • Pathology
  • Pharmaceutical
  • Biopharmaceutical
  • World
  • China
  • Japan
  • Stem Cell Transplantation
  • Drug Approval

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...

  • Biopharmaceutical
  • Biochemical
  • World
  • Biologics Production

Abstract: - Global Biopharmaceuticals Market to Reach $535 Billion by 2027 - Amid the COVID-19 crisis, the global market for Biopharmaceuticals estimated at US$234.5 Billion in the year 2020, is projected to reach a revised size of US$535 Billion by 2027, growing at a CAGR of 12.5% over the analysis period 2020-2027....

  • Biopharmaceutical
  • World
  • China
  • United States

Degenerative Disc Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players,...

  • Cell Therapy
  • Pharmaceutical
  • Therapy
  • Biopharmaceutical
  • Drug Development
  • World
  • United States

Apoptosis Regulator BAX - Drugs In Development, 2021 Summary Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Apoptosis regulator BAX or bcl-2-like protein 4 is a protein is encoded by the BAX gene. It accelerates programmed cell death by antagonizing the apoptosis repressor BCL2....

  • Dementia
  • Biopharmaceutical
  • Lung Cancer
  • Heart Attack
  • Leukemia
  • World
  • Cause-Specific Mortality Rate
  • Drug Approval

The Europe biopharmaceutical tubing market is expected to reach US$ 1,474.45 million by 2028 from US$ 827.65 million in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as increasing elderly population in world, and rising demand for minimally...

  • Biopharmaceutical
  • Europe
  • Elderly Population
  • Chronic Disease Prevalence

The North America biopharmaceutical tubing market is expected to reach US$ 3,090.82 million by 2028 from US$ 1,803.70 million in 2021; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as increasing elderly population in world, and rising demand for minimally...

  • Biopharmaceutical
  • North America
  • Elderly Population
  • Chronic Disease Prevalence

The Asia Pacific biopharmaceutical tubing market is expected to reach US$ 903.19 million by 2028 from US$ 487.50 million in 2021; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. The growth of the market is attributed to key factors such as increasing elderly population in world and proliferation of healthcare sector in...

  • Biopharmaceutical
  • APAC
  • Chronic Disease Prevalence
  • Elderly Population

The South and Central America biopharmaceutical tubing market is expected to reach US$ 318.10 million in 2028 from US$ 187.63 million in 2021; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as increasing elderly population in world, and rising demand...

  • Biopharmaceutical
  • Central America
  • Elderly Population
  • Chronic Disease Prevalence

The Middle East and Africa biopharmaceutical tubing market is expected to reach US$ 226.70 million by 2028 from US$ 136.34 million in 2021; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as increasing elderly population in world, and rising demand...

  • Biopharmaceutical
  • Middle East
  • Africa
  • Chronic Disease Prevalence
  • Health Expenditure

Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Metabotropic glutamate receptor 1 (mGluR1) is a protein...

  • Therapy
  • Drug Development
  • Biopharmaceutical
  • World

Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Paroxysmal Nocturnal Hemoglobinuria – Drugs In Development, 2022, provides an overview of the Paroxysmal...

  • Biopharmaceutical
  • World
  • Medical Technology Density

The biopharmaceutical tubing market is expected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million in 2021; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The factors increasing elderly population in world, and rising demand for minimally invasive procedures are contributing to the market growth. However, the stringent...

  • Biopharmaceutical
  • World
  • APAC
  • Europe
  • Middle East
  • Chronic Disease Prevalence
  • Health Expenditure

Report Scope: The report summarizes the market, including a market snapshot and company profiles of key players in the sole-use technologies market.It provides a comprehensive market breakdown with in-depth information about each segment. The overview section of the report describes market trends and dynamics, including...

  • Biopharmaceutical
  • World
  • Export

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF)...

  • Psychotic Disorder
  • Gene Therapy
  • World
  • Direct Sales

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Drugs in Development, 2021 Summary Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) pipeline Target constitutes close to 7 molecules. Out of which approximately 2 molecules...

  • Oncology
  • Breast Cancer
  • Protein Therapy
  • World
  • Cause-Specific Mortality Rate
  • Drug Approval

The global biopharmaceuticals market is found witnessing a CAGR of 7.32%. The market is largely driven by the growing geriatric population, increasing burden of chronic diseases, and rising inclination toward targeted therapy. Also, the huge demand of biopharmaceutical is facilitated by an accelerating focus in research and related investment. The...

  • Biopharmaceutical
  • Monoclonal Antibody
  • Infectious Disease
  • Vaccine
  • Protein Therapy
  • Biotech Vaccine
  • APAC
  • Health Expenditure
  • Drug Approval

Abstract: - Global Biopharmaceutical Fermentation Systems Market to Reach $14.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Biopharmaceutical Fermentation Systems estimated at US$10.9 Billion in the year 2020, is projected to reach a revised size of US$14.8 Billion by 2027, growing at aCAGR of...

  • Biotechnology
  • Medical Biotechnology
  • Biopharmaceutical
  • World
  • China
  • United States

INTRODUCTION Given the various advantages of biologics, such as high specificity for their intended molecular targets, ability to treat a myriad of disease indications, and patient friendly toxicity profiles, the demand for such interventions is high. In 2020 alone, more than 20 biopharmaceutical products (including monoclonal...

  • Biopharmaceutical
  • World
  • APAC
  • MENA
  • Europe
  • North America
  • Latin America

Forecasts by Source (Mammalian, Non-mammalian), by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & QC Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, & Molecular Therapy, Others), Biosimilars), by Company...

  • Biopharmaceutical
  • World
  • United States
  • Health Provider Density

Kidney Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Kidney Fibrosis - Drugs In Development, 2022, provides an overview of the Kidney Fibrosis (Genito Urinary System And...

  • Pharmaceutical
  • Drug Development
  • Therapy
  • Gene Therapy
  • Mortality Rate

Paroxysmal Nocturnal Hemoglobinuria (Hematology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Paroxysmal Nocturnal Hemoglobinuria - Drugs In Development, 2021, provides an overview of the Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders)...

  • Biopharmaceutical
  • Drug Development
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021 Summary According to the recently published report ’Insulin Like Growth Factor I - Drugs In Development, 2021’; Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1)...

  • Therapy
  • Biopharmaceutical
  • Breast Cancer
  • Cell Therapy
  • Targeted Therapy
  • Chronic Pain
  • Protein Therapy
  • World
  • Cause-Specific Mortality Rate
  • Drug Approval

The biopharmaceutical contract manufacturing market is expected to grow at a CAGR of 14.37% during 2022-2027. Biopharmaceutical companies rely on contract manufacturing organizations (CMOs) to provide capabilities and skills as needed. The CMO has provided most of the company’s production in some cases. The market is mainly growing...

  • Biopharmaceutical
  • World
  • Biosimilar Approvals
  • Elderly Population

Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Female Hypoactive Sexual Desire Disorder - Drugs In Development, 2022, provides an overview...

  • Pharmaceutical
  • Therapy
  • Drug Development
  • Biopharmaceutical
  • World
  • Depression Prevalence
  • Drug Approval